THERAPEUTIC SEGMENT:

Anti-Hypertensive

INDICATIONS:

Nibovo HCT is a fixed dose combination, indicated for the treatment of essential hypertension

BRIEF DESCRIPTION:

Nibovo HCT is a combination of nebivolol, a selective beta-receptor antagonist,  and hydrochlorothiazide, a thiazide  diuretic.  The combination of these ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

DOSAGE FORM:

Tablets

5mg+12.5mg

5mg+25mg

Disclaimer: For use under medical prescription only